Neola Medical AB (publ) (STO:NEOLA)

Neola Medical AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	16.12	19.56	21.58	40.09	22.94
Cash & Short-Term Investments	16.12	19.56	21.58	40.09	22.94
Cash Growth	-17.55%	-9.38%	-46.17%	74.76%	37.80%
Accounts Receivable	1.11	-	-	-	-
Other Receivables	-	1.07	20.9	1.02	1.45
Receivables	1.11	1.07	20.9	1.02	1.45
Prepaid Expenses	-	0.42	0.63	0.49	0.4
Other Current Assets	-	-	-	-0	-
Total Current Assets	17.24	21.04	43.11	41.6	24.79
Property, Plant & Equipment	0.22	0.2	0.14	0.22	0.16
Long-Term Deferred Charges	61.22	52.37	42.78	33.51	18.88
Other Long-Term Assets	0.13	-	-	-	0
Total Assets	78.8	73.61	86.02	75.33	43.83
Accounts Payable	-	1.07	2.18	1.49	1.3
Accrued Expenses	1.56	2	1.62	1.79	1.44
Current Income Taxes Payable	-	0.1	0.09	0.08	0.05
Other Current Liabilities	1.44	1.49	2.27	1.98	0.41
Total Current Liabilities	3	4.65	6.16	5.35	3.19
Other Long-Term Liabilities	-	-	0.83	2.5	-
Total Liabilities	3	4.65	6.99	7.85	3.19
Common Stock	75.8	5.01	3.98	3.98	1.5
Additional Paid-In Capital	-	99.08	80.11	79.56	44.83
Retained Earnings	-	-35.13	-25.06	-16.05	-5.7
Comprehensive Income & Other	-	-	20	-	-
Shareholders' Equity	75.8	68.96	79.03	67.49	40.63
Total Liabilities & Equity	78.8	73.61	86.02	75.33	43.83
Net Cash (Debt)	16.12	19.56	21.58	40.09	22.94
Net Cash Growth	-17.55%	-9.38%	-46.17%	74.76%	37.80%
Net Cash Per Share	0.21	0.28	0.39	1.54	1.64
Filing Date Shares Outstanding	77.95	70.15	70.15	55.69	21.05
Total Common Shares Outstanding	77.95	70.15	55.69	55.69	21.05
Working Capital	14.24	16.39	36.95	36.26	21.59
Book Value Per Share	0.97	0.98	1.42	1.21	1.93
Tangible Book Value	75.8	68.96	79.03	67.49	40.63
Tangible Book Value Per Share	0.97	0.98	1.42	1.21	1.93
Machinery	-	0.46	0.31	0.31	0.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.